DC cell culture method, culture medium, DC treatment strategy-based drug and application of tyrosine kinase inhibitor in preparation of DC cell culture medium
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SICHUAN PROVINCIAL PEOPLES HOSPITAL
- Publication Date
- 2021-05-28
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the related technical field of DC cells, in particular to a method for culturing DC cells, a culture medium, a drug based on a DC treatment strategy, and an application of a tyrosine kinase inhibitor in the preparation thereof. Background technique
[0002] DC cells (dendritic cells), as the most important antigen-presenting cells, can play an important role in anti-tumor immunity by priming naive T cells and promoting their proliferation and differentiation into Th cells and cytotoxic T lymphocytes (CTL) .
[0003] In the past few decades, anti-tumor treatment strategies based on DC cells have developed rapidly; for example, cultivating autologous dendritic cells to enhance their activity, and then reinfusing them into patients is the cutting-edge technology of current research and application. Not only can it effectively stimulate the anti-tumor immune response in tumor patients, and it has shown good curative effect in rese...